Literature DB >> 25769353

Adenomatous tumors of the middle ear.

Stanley Pelosi1, Shira Koss2.   

Abstract

Adenomatous tumors are an uncommon cause of a middle ear mass. Clinical findings may be nonspecific, leading to difficulties in differentiation from other middle ear tumors. Controversy also exists whether to classify middle ear adenoma and carcinoid as separate neoplasms, or alternatively within a spectrum of the same pathologic entity. Most adenomatous middle ear tumors are indolent in behavior, with a benign histologic appearance and slowly progressive growth. The mainstay of treatment is complete surgical resection, which affords the greatest likelihood of cure.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenomatous middle ear tumor; Amphicrine tumor; Middle ear adenoma; Middle ear carcinoid; Mixed adenoma; Neuroendocrine adenoma

Mesh:

Year:  2015        PMID: 25769353     DOI: 10.1016/j.otc.2014.12.005

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  5 in total

Review 1.  Ceruminous Neoplasms of the Ear.

Authors:  Priyadharsini Nagarajan
Journal:  Head Neck Pathol       Date:  2018-08-01

Review 2.  Neuroendocrine Neoplasms of the Ear.

Authors:  Nora Katabi
Journal:  Head Neck Pathol       Date:  2018-08-01

Review 3.  [Neuroendocrine neoplasms of the auditory, olfactory, and visual sensory organs].

Authors:  B Sipos
Journal:  Pathologe       Date:  2018-05       Impact factor: 1.011

Review 4.  Adenomatous Tumors of the Middle Ear: A Literature Review.

Authors:  Flavia Amarante Cardoso; Eduardo Machado Rossi Monteiro; Livia Bernardi Lopes; Marianna Novaes da Costa Avila; Bernardo Oliveira Scarioli
Journal:  Int Arch Otorhinolaryngol       Date:  2017-04-28

Review 5.  Middle Ear Neuroendocrine Tumor: A Case Report and Review of the Literature in Pediatric Population.

Authors:  Mariapaola Guidi; Annamaria Buccoliero; Franco Trabalzini
Journal:  J Int Adv Otol       Date:  2021-03       Impact factor: 1.316

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.